SG Americas Securities’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27K | Sell |
23,343
-761
| -3% | -$880 | ﹤0.01% | 2460 |
|
|
2025
Q1 | $38K | Sell |
24,104
-32,285
| -57% | -$50.9K | ﹤0.01% | 2903 |
|
|
2024
Q4 | $171K | Buy |
56,389
+30,240
| +116% | +$91.7K | ﹤0.01% | 2040 |
|
|
2024
Q3 | $96K | Buy |
26,149
+11,997
| +85% | +$44K | ﹤0.01% | 2751 |
|
|
2024
Q2 | $58K | Buy |
+14,152
| New | +$58K | ﹤0.01% | 2302 |
|
|
2024
Q1 | – | Sell |
-152,747
| Closed | -$2.31M | – | 3064 |
|
|
2023
Q4 | $2.31M | Buy |
152,747
+6,252
| +4% | +$94.7K | 0.02% | 547 |
|
|
2023
Q3 | $2.94M | Buy |
146,495
+72,861
| +99% | +$1.46M | 0.03% | 469 |
|
|
2023
Q2 | $2.08M | Buy |
+73,634
| New | +$2.08M | 0.02% | 661 |
|
|
2022
Q3 | – | Sell |
-28,886
| Closed | -$812K | – | 3187 |
|
|
2022
Q2 | $812K | Buy |
28,886
+19,052
| +194% | +$536K | 0.01% | 1337 |
|
|
2022
Q1 | $454K | Sell |
9,834
-9,650
| -50% | -$446K | ﹤0.01% | 1739 |
|
|
2021
Q4 | $1.64M | Buy |
19,484
+773
| +4% | +$65K | 0.01% | 1152 |
|
|
2021
Q3 | $1.25M | Buy |
18,711
+7,346
| +65% | +$490K | 0.01% | 1561 |
|
|
2021
Q2 | $605K | Sell |
11,365
-3,966
| -26% | -$211K | ﹤0.01% | 1680 |
|
|
2021
Q1 | $665K | Buy |
15,331
+7,429
| +94% | +$322K | ﹤0.01% | 1644 |
|
|
2020
Q4 | $410K | Sell |
7,902
-43,520
| -85% | -$2.26M | ﹤0.01% | 1879 |
|
|
2020
Q3 | $1.68M | Buy |
51,422
+45,825
| +819% | +$1.5M | 0.01% | 690 |
|
|
2020
Q2 | $269K | Buy |
+5,597
| New | +$269K | ﹤0.01% | 2237 |
|